phosphatidylcholines has been researched along with phorbol-12,13-dibenzoate in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (phorbol-12,13-dibenzoate) | Trials (phorbol-12,13-dibenzoate) | Recent Studies (post-2010) (phorbol-12,13-dibenzoate) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 16 | 0 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, A; Mellors, A; Stalmach, ME | 1 |
1 other study(ies) available for phosphatidylcholines and phorbol-12,13-dibenzoate
| Article | Year |
|---|---|
Co-mitogenic tumor promoters suppress the phosphatidylinositol response in lymphocytes during early mitogenesis.
Topics: Animals; Carcinogens; Female; Humans; Lymphocyte Activation; Mice; Phorbol Esters; Phorbols; Phosphates; Phosphatidylcholines; Phosphatidylinositols; Phytohemagglutinins; T-Lymphocytes; Tetradecanoylphorbol Acetate; Thymidine | 1985 |